| Source: |
| Type: |
| Cancer and inflammation are closely linked, with chronic inflammation contributing to the development and progression of cancer. Various inflammatory mediators and cells are involved in this process. |
| Colon cancer can start anywhere in the colon, (5 feet long) and absorbs water from stool. Rectal cancer starts in the rectum, which is the last 12 centimeters. |
| 6083- | CHOC, | Preventive Effects of Cocoa and Cocoa Antioxidants in Colon Cancer |
| - | Review, | Colon, | NA |
| 7414- | CS, | Pro-Apoptotic Activity of Artichoke Leaf Extracts in Human HT-29 and RKO Colon Cancer Cells |
| - | in-vitro, | Colon, | HT29 | - | in-vitro, | CRC, | RKO |
| 6701- | DFC, | Intracellular pH and calcium signaling as molecular targets of diclofenac-induced apoptosis against colon cancer |
| - | in-vivo, | Colon, | NA |
| 6709- | DFC, | Diclofenac induced apoptosis via altering PI3K/Akt/MAPK signaling axis in HCT 116 more efficiently compared to SW480 colon cancer cells |
| - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Colon, | SW480 |
| 6666- | DFE, | The impact of date palm fruits and their component polyphenols, on gut microbial ecology, bacterial metabolites and colon cancer cell proliferation |
| - | in-vitro, | Colon, | Caco-2 |
| 6383- | Eug, | In Vitro Incorporation of Radioiodinated Eugenol on Adenocarcinoma Cell Lines (Caco2, MCF7, and PC3) |
| - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Pca, | PC3 |
| 6389- | Eug, | Molecular Insights into the Management of Eugenol's Anticancer Action Against Colon Cancer: A Detailed Review |
| - | Review, | Colon, | NA |
| 6909- | FIS, | Modulation of PI3K/ AKT/ mTOR and apoptosis pathway in colon cancer cells by the plant flavonoid fisetin |
| - | in-vitro, | Colon, | Caco-2 |
| 6984- | Form, | Formononetin suppresses colitis-associated colon cancer by targeting lipid synthesis and mTORC2/Akt signaling |
| - | in-vitro, | Colon, | HCT116 | - | Review, | IBD, | RAW264.7 |
| 7052- | Gallo, | Galloflavin Relieves the Malignant Behavior of Colorectal Cancer Cells in the Inflammatory Tumor Microenvironment |
| - | in-vivo, | Colon, | SW48 |
| 4508- | GLA, | aLinA, | α-Linolenic and γ-linolenic acids exercise differential antitumor effects on HT-29 human colorectal cancer cells |
| - | in-vitro, | Colon, | HT29 |
| 1637- | HCA, | OLST, | Orlistat and Hydroxycitrate Ameliorate Colon Cancer in Rats: The Impact of Inflammatory Mediators |
| - | in-vivo, | Colon, | NA |
| 3278- | Lyco, | Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells |
| - | in-vitro, | Colon, | SW480 |
| 4781- | Lyco, | 5-FU, | Chemo, | Cisplatin, | Antioxidant and anti-inflammatory activities of lycopene against 5-fluorouracil-induced cytotoxicity in Caco2 cells |
| - | in-vitro, | Colon, | Caco-2 |
| 6433- | T4O, | CET, | Terpinen-4-ol: A Novel and Promising Therapeutic Agent for Human Gastrointestinal Cancers |
| - | in-vitro, | Colon, | HT29 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | PC, | COLO357 | - | Human, | Colon, | NA |
| 6459- | TUR, | Curcumin combined with turmerones, essential oil components of turmeric, abolishes inflammation-associated mouse colon carcinogenesis |
| - | in-vivo, | Nor, | NA | - | in-vivo, | Colon, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:31 Cells:% prod#:% Target#:953 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid